Linked Life Data

16274835

Source:http://linkedlifedata.com/resource/pubmed/id/16274835

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2005-12-12
pubmed:abstractText
Adefovir dipivoxil (10 mg once-daily) was added to antiretroviral therapy including lamivudine in 35 HIV/HBV co-infected patients.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0168-8278
pubmed:author
pubmed:issnType
Print
pubmed:volume
44
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
62-7
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:16274835-AIDS-Related Opportunistic Infections, pubmed-meshheading:16274835-Adenine, pubmed-meshheading:16274835-Adult, pubmed-meshheading:16274835-Antiviral Agents, pubmed-meshheading:16274835-Drug Resistance, Viral, pubmed-meshheading:16274835-Female, pubmed-meshheading:16274835-Follow-Up Studies, pubmed-meshheading:16274835-HIV-1, pubmed-meshheading:16274835-Hepatitis B, Chronic, pubmed-meshheading:16274835-Hepatitis B virus, pubmed-meshheading:16274835-Humans, pubmed-meshheading:16274835-Lamivudine, pubmed-meshheading:16274835-Male, pubmed-meshheading:16274835-Phosphonic Acids, pubmed-meshheading:16274835-Pilot Projects, pubmed-meshheading:16274835-Polymerase Chain Reaction, pubmed-meshheading:16274835-Prospective Studies, pubmed-meshheading:16274835-RNA, Viral, pubmed-meshheading:16274835-Treatment Outcome
pubmed:year
2006
pubmed:articleTitle
Safety and efficacy of adefovir dipivoxil in patients infected with lamivudine-resistant hepatitis B and HIV-1.
pubmed:affiliation
Groupe Hospitalier Pitie-Salpetriere, Service de d'Hépato-Gastroentérologie, Paris, France. ybenhamou@teaser.fr
pubmed:publicationType
Journal Article, Comparative Study